CYCLO THERAPEUTICS
Cyclo Therapeutics is a clinical-stage biotechnology company focused on the use of cyclodextrins in drug development. Cyclo Therapeutics (previously CTD Holdings) was organized as a Florida corporation on August 9, 1990, with operations beginning in July 1992. In conjunction with a restructuring in 2000, they changed their name from Cyclodextrin Technologies Development, or CTDI, to CTD Holdings. CTDI was then incorporated as a Florida corporation and became a wholly-owned subsidiary of CTD Holdings.
CYCLO THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
1990-01-01
Address:
Alachua, Florida, United States
Country:
United States
Website Url:
http://www.cyclotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(386) 418-8060
Email Addresses:
[email protected]
Total Funding:
9.68 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Key Employee Changes
Official Site Inspections
http://www.cyclotherapeutics.com Semrush global rank: 3.51 M Semrush visits lastest month: 4.22 K
- Host name: lamp108.cloudaccess.net
- IP address: 199.116.77.19
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cyclo Therapeutics"
Our Commitment - cyclotherapeutics
While our commitment to serving patients is engrained throughout every part of our organization, the Patient Advocacy function at Cyclo Therapeutics serves as a liaison between our company …See details»
Leadership Team - cyclotherapeutics
A graduate of Boston College, Lori is a hands-on mom of two boys and is an active volunteer in her community. She also serves on the Board of a nonprofit organization called Our Odyssey. Our Odyssey connects young adults …See details»
Cyclo Therapeutics - Crunchbase Company Profile
Cyclo Therapeutics is a clinical-stage biotechnology company that focuses on the use of cyclodextrins in drug development.See details»
Cyclo Therapeutics, Inc. Overview | SignalHire Company Profile
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with …See details»
Cyclo Therapeutics - businessabc
Feb 18, 2025 Cyclo Therapeutics was founded in 2017 by a team of dedicated scientists and clinical researchers. Since our founding, we have focused on finding novel solutions to provide …See details»
Cyclo Therapeutics, Inc. (CYTHW) Company Profile & Overview
Mar 3, 2025 Company profile for Cyclo Therapeutics, Inc. (CYTHW) with a description, list of executives, contact details and other key facts.See details»
Organization | Cyclotherapeutics
Founded: Alachua FL United States (1990)Status: Left NME R&D (2024)See details»
Cyclo Therapeutics, Inc. - LinkedIn
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with …See details»
Cyclo Therapeutics Provides Business Update
Sep 28, 2022 Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-cSee details»
Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular ...
Dec 27, 2023 Combined company operating as Cyclo Therapeutics with primary focus on advancing Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1) …See details»
Gerald F. Cox - Acting Chief Medical Officer at Cyclo ... - The Org
Dr. Cox is board-certified by the American College of Medical Genetics and Genomics in Clinical, Biochemical, and Molecular Genetics, and he was board-certified by the American Academy of …See details»
Cyclo Therapeutics - Craft
Cyclo Therapeutics has 5 employees across 2 locations and $1.08 m in annual revenue in FY 2023. See insights on Cyclo Therapeutics including office locations, competitors, revenue, …See details»
Cyclo Therapeutics Announces Launch of New Website
Jun 15, 2021 The Company is on track to file its IND for a Phase 2 study of Alzheimer’s disease in the second half of 2021. For more information, please visit cyclotherapeutics.com . About …See details»
Cyclo Therapeutics - Overview, News & Similar companies
View Cyclo Therapeutics (www.cyclotherapeutics.com) location in Florida, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Pipeline - cyclotherapeutics
Ongoing Collaboration with University of the Witwatersrand, Johannesburg to Advance Trappsol® Cyclo™ Platform and Explore Pipeline Expansion OpportunitiesSee details»
Cyclo Therapeutics, Inc. (CYTHW) - Yahoo Finance
Find the latest Cyclo Therapeutics, Inc. (CYTHW) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Cyclo Therapeutics Unveils New Corporate Identity and Reaffirms ...
Feb 22, 2021 For more information about the Cyclo Therapeutics and its pipeline of products in development, please visit: www.cyclotherapeutics.com About Cyclo TherapeuticsSee details»
Cyclo Therapeutics merges with longtime backer Rafael Holdings
Aug 22, 2024 With just weeks to go before the FDA decides whether to approve the first treatment for a rare genetic condition, Rafael Holdings is merging with Cyclo Therapeutics to …See details»
Cyclo Therapeutics to Present at the China NPC Association Meeting
Aug 8, 2022 GAINESVILLE, Fla. – Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to …See details»